HUMAN .BETA.-AMYLOID PEPTIDE (1-40)

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 22:44:20 GMT 2025` Edited by `admin` on `Mon Mar 31 22:44:20 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	13539D6GO8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

A.BETA.40

Preferred Name

English

HUMAN .BETA.-AMYLOID PEPTIDE (1-40)

Common Name

English

AMYLOID .BETA. PEPTIDE(1-40) (SYNTHETIC)

Common Name

English

ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL

Common Name

English

A.BETA.(1-40)

Common Name

English

.BETA.-AMYLOID PROTEIN(1-40)

Common Name

English

HUMAN .BETA.-AMYLOID PEPTIDE-(1-40)

Common Name

English

A.BETA.40 [MI]

Common Name

English

Code System Code Type Description

CHEBI

64646

Created by admin on Mon Mar 31 22:44:20 GMT 2025 , Edited by admin on Mon Mar 31 22:44:20 GMT 2025

PRIMARY

MERCK INDEX

m1878

Created by admin on Mon Mar 31 22:44:20 GMT 2025 , Edited by admin on Mon Mar 31 22:44:20 GMT 2025

PRIMARY

Merck Index

EPA CompTox

DTXSID50856170

Created by admin on Mon Mar 31 22:44:20 GMT 2025 , Edited by admin on Mon Mar 31 22:44:20 GMT 2025

PRIMARY

CAS

131438-79-4

Created by admin on Mon Mar 31 22:44:20 GMT 2025 , Edited by admin on Mon Mar 31 22:44:20 GMT 2025

PRIMARY

FDA UNII

13539D6GO8

Created by admin on Mon Mar 31 22:44:20 GMT 2025 , Edited by admin on Mon Mar 31 22:44:20 GMT 2025

PRIMARY

PUBCHEM

57339250

Created by admin on Mon Mar 31 22:44:20 GMT 2025 , Edited by admin on Mon Mar 31 22:44:20 GMT 2025

PRIMARY

Related Record Type Details


					11VWK61J69

INHIBITOR -> TARGET


					UH32L7RML6

LIGAND->TARGET

Comments:

Targets soluble A? monomer to shift oligomer equilibrium and prevent direct neurotoxicity from soluble forms.


					5D6PWO0333

LIGAND->TARGET

Comments:

Designed to increase the clearance from the brain of soluble A?, peptides that may lead to toxic effects in the synapses and precede the deposition of fibrillary amyloid.

Amount:


					O8AS5277H0

INHIBITOR -> TARGET


					C35RF1MWQZ

INHIBITOR OF RELEASE->TARGET

Amount:


					F7MN148019

RN-6G

INHIBITOR -> TARGET


					5K8EAX0G53

INHIBITOR OF AGGREGATION->TARGET

Comments:

A? was maintained in a random-coil/?-helical rich conformation in the presence of Tramiprosate at a 20:1 ratio of Tramiprosate:A?. Binds and shows anti-fibrillogenic activity.

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:SEQUENCE(CALCULATED)	CHEMICAL